Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amifostine in Myelodysplastic Syndrome
NCT00003048Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jun 1997
- Primary completion
- Feb 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of amifostine in myelodysplastic syndrome (MDS), sponsored by University of Texas MD Anderson Cancer Center. Started Jun 1997; status: completed.
02
Drugs
amifostine
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT00003048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003048.